T T Sreelekha Selected Research

T T Sreelekha Research Topics

Disease

23	Neoplasms (Cancer) 02/2021 - 12/2000
4	Ascites 02/2021 - 01/2014
3	Breast Neoplasms (Breast Cancer) 09/2019 - 01/2012
3	Leukemia 03/2017 - 01/2012
3	Carcinoma (Carcinomatosis) 04/2014 - 12/2000
2	Lung Neoplasms (Lung Cancer) 09/2019 - 11/2010
2	Neoplasm Metastasis (Metastasis) 08/2019 - 10/2017
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2016 - 02/2015
1	Nephrogenic Fibrosing Dermopathy 01/2021
1	Adenocarcinoma of Lung 09/2019
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 03/2017
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 09/2016
1	Melanoma (Melanoma, Malignant) 01/2016
1	Candidiasis (Moniliasis) 04/2015
1	Lymphoma (Lymphomas) 01/2014
1	Nasopharyngeal Carcinoma 01/2012
1	Mouth Neoplasms (Oral Cancer) 10/2001
1	Carcinogenesis 10/2001
1	Adenoma (Adenomas) 12/2000

Drug/Important Bio-Agent (IBA)

8	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2021 - 11/2013
8	galactoxyloglucanIBA 02/2021 - 04/2014
7	Pharmaceutical PreparationsIBA 01/2021 - 01/2014
5	PST001IBA 01/2021 - 01/2012
5	Polysaccharides (Glycans)IBA 09/2020 - 01/2012
4	GoldIBA 01/2021 - 04/2013
4	NanoconjugatesIBA 01/2021 - 04/2014
3	Folic Acid (Vitamin M)FDA LinkGeneric 01/2021 - 04/2016
3	Antineoplastic Agents (Antineoplastics)IBA 02/2015 - 01/2012
2	Proteins (Proteins, Gene)FDA Link 09/2020 - 09/2019
2	galactomannanIBA 10/2018 - 10/2017
2	CaspasesIBA 10/2018 - 04/2016
2	Fluorouracil (Carac)FDA LinkGeneric 01/2014 - 01/2012
2	Cytochrome P-450 CYP1A1 (CYP1A1)IBA 11/2010 - 10/2001
1	GadoliniumIBA 01/2021
1	Contrast MediaIBA 01/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021
1	Silicon Dioxide (Silica)FDA LinkGeneric 01/2021
1	MetalsIBA 09/2020
1	Therapeutic UsesIBA 09/2020
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 09/2019
1	Paclitaxel (Taxol)FDA LinkGeneric 09/2019
1	AntioxidantsIBA 10/2018
1	SilverIBA 10/2018
1	Vincristine (Oncovin)FDA LinkGeneric 10/2017
1	Imatinib Mesylate (Gleevec)FDA Link 03/2017
1	Biopolymers (Biopolymer)IBA 03/2017
1	bcr-abl Fusion ProteinsIBA 03/2017
1	liposomal doxorubicin (Doxil)FDA Link 04/2016
1	pseudopyronine BIBA 01/2016
1	Acridine OrangeIBA 01/2016
1	Ethidium (Ethidium Bromide)IBA 01/2016
1	Annexin A5IBA 01/2016
1	Anti-Infective Agents (Microbicides)IBA 04/2015
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2015
1	Biological ProductsIBA 02/2015
1	LigandsIBA 02/2015
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2014
1	xanthorrhizolIBA 01/2014
1	naphthaIBA 01/2014
1	marmelosinIBA 01/2014
1	Immunologic Factors (Immunomodulators)IBA 01/2012
1	Estradiol (Delestrogen)FDA LinkGeneric 11/2010
1	Estrogens (Estrogen)FDA Link 11/2010
1	Interleukin-6 (Interleukin 6)IBA 11/2010
1	CarcinogensIBA 10/2001
1	Isoleucine (L-Isoleucine)FDA Link 10/2001
1	Valine (L-Valine)FDA Link 10/2001
1	EnzymesIBA 10/2001
1	isoleucylvalineIBA 10/2001
1	Glycoproteins (Glycoprotein)IBA 12/2000
1	CarbohydratesIBA 12/2000
1	GlycoconjugatesIBA 12/2000
1	LectinsIBA 12/2000

Therapy/Procedure

5	Drug Therapy (Chemotherapy) 01/2021 - 01/2014
5	Therapeutics 01/2021 - 02/2015
1	Precision Medicine 09/2016
1	Immunomodulation 01/2012